RESPINOVA
Respinova is developing breakthrough treatments for COPD and other respiratory diseases.
RESPINOVA
Industry:
Medical Device
Founded:
2008-01-01
Address:
Herzliya, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.respinova.com
Total Employee:
1+
Status:
Active
Contact:
+972-58-687-8812
Email Addresses:
[email protected]
Total Funding:
3.52 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Google Cloud Sectigo SSL Sectigo Domain SSL
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Be Biopharma
Be Biopharma is developing B ceaBe Biopharma is a biotech research company that develops a class of B cells as medicines.lls as medicines.
Sesen Bio, Inc.
Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
RightAir
RightAir is developing noninvasive ventilators for COPD patients.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Respinova
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Respinova
Official Site Inspections
http://www.respinova.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Respinova"
Respinova - Crunchbase Company Profile & Funding
Respinova provides pulmonary treatment devices. It develops a novel non-invasive technology, PulseHaler, that treats the core of COPD pathophysiology. They serve COPD patients.See details»
Respinova Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Respinova. Use the PitchBook Platform to explore the full profile.See details»
Respinova - Foreign Startup | Startup Nation Finder
Nov 12, 2019 · Respinova Overview Respinova has developed the PulseHaler, a noninvasive technology that aims to treat the core pathophysiology of chronic obstructive pulmonary …See details»
Respinova Ltd. - LinkedIn
Respinova Ltd. | 298 followers on LinkedIn. Respinova has developed a novel non-invasive technology, PulseHaler, that aims to treat the core of COPD pathophysiology.See details»
Respinova - Overview, News & Competitors | ZoomInfo.com
Apr 6, 2021 · Respinova is a privately held medical technology company based in Herzliya, Israel. Our team has decades of experience in developing and commercializing innovative medical …See details»
COPD innovation may keep Covid patients off ventilators
Jun 1, 2020 · Long before the pandemic began, Israeli startup Respinova was developing Pulsehaler, a novel medical device to help chronic obstructive pulmonary disease patients improve their lungs and avoid ventilation. COPD …See details»
Respinova - Products, Competitors, Financials, Employees, …
Respinova is a medical device company focused on developing treatments for Chronic Obstructive Pulmonary Disease (COPD). The company's main product, the PulseHaler, is a …See details»
Respinova - Funding, Financials, Valuation & Investors - Crunchbase
Respinova is funded by 2 investors. European Innovation Council and European Innovation Council are the most recent investors. Which investors participated in the most funding rounds?See details»
Respinova - Crunchbase
Respinova is develops treatments for COPD and respiratory diseases.See details»
FDA approves health startup Respinova's Pulsehaler for …
Apr 7, 2021 · Herzliya-based health tech startup Respinova Ltd. has received 510 (k) clearance from the US Food and Drug Administration (FDA) to market its Pulsehaler device for patients with respiratory problems, the company …See details»
Pulsehalerâ„¢ Granted FDA 510 (k) Clearance - Vincent Medical
Apr 6, 2021 · Respinova Ltd. is pleased to announce that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Pulsehalerâ„¢. Pulsehalerâ„¢ is an …See details»
FDA greenlights Respinova's Pulsehaler | 2021-04-07 - BioWorld
Apr 7, 2021 · The management team at Respinova Ltd. is breathing easier with the FDA's 510(k) clearance of the company's Pulsehaler. Using pulsed air pressure, the device opens airways …See details»
#MedtechRoadshow Chapter 1 - Respinova - LinkedIn
May 26, 2020 · Respinova’s Pulsehalerâ„¢ uses patented multi-frequency air pressure pulses to directly re-open these collapsed small airways, thereby reducing breathlessness and …See details»
Respinova - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Respinova is develops treatments for COPD and respiratory diseases.See details»
Respinova Granted FDA 510(k) Clearance for Pulsehaler
Jun 10, 2021 · Respinova has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Pulsehalerâ„¢. Pulsehalerâ„¢ is an innovative device that …See details»
Respinova Granted FDA 510(k) Clearance for Pulsehaler™ - PR …
HERZLIYA, Israel, April 6, 2021 /PRNewswire/ -- Respinova Ltd. is pleased to announce it has received 510 (k) clearance from the U.S. Food and Drug Administration (FDA) to market …See details»
Respinova Granted FDA 510 (k) Clearance for Pulsehalerâ„¢
HERZLIYA, Israel, April 6, 2021 /PRNewswire/ -- Respinova Ltd. is pleased to announce it has received 510 (k) clearance from the U.S. Food and Drug Administration (FDA) to market …See details»
Respinova - Contacts, Employees, Board Members, Advisors
Respinova has 4 current employee profiles, including CMO Noam Gavriely. Respinova is develops treatments for COPD and respiratory diseases.See details»
Respinova’s Pulsehaler Device for CF Wins FDA OK
Apr 12, 2021 · Pulsehaler is a non-invasive device that generates unique pulses of air pressure, using Respinova’s dynamic multi-frequency pressure pulse technology. Built with a turbine and …See details»
Respinova Syrup: Find Respinova Syrup Information Online - Lybrate
Respinova Syrup is an ayurvedic formulation that soothe the throat to relieve cough and provides relief from irritation in throat due to cough. It is also to relieve cough caused by the common …See details»